RxDoctor Payments Data

John Dumot, DO

Gastroenterology · Cleveland, OHNPI 1609813484

Payments from drug & device makers

$16,775in general payments, 2019–2025

Across 101 payments — averaging $166.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • US Endoscopy$15K
  • AbbVie$794
  • Takeda Pharmaceuticals U.S.A., Inc.$258
  • Aimmune Therapeutics, Inc.$184
  • Pfizer$144
  • Phathom Pharmaceuticals, Inc.$122
  • plus $478 from 10 others

What the payments were for

  • Consulting fees$13,19587%
  • Food & beverage$1,98013%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,775 in reported general payments places this provider in the 75th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$83,601
Medicare patients
421
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase98$122,462
LinzessLinaclotide58$37,064
ZenpepLipase/Protease/Amylase15$18,307
Mesalamine15$9,290
MotegrityPrucalopride Succinate14$9,102
TrulancePlecanatide13$7,069
Lansoprazole33$6,536
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates102$6,475
Colesevelam Hcl21$4,754
CholestyramineCholestyramine (With Sugar)49$3,905
Esomeprazole Magnesium77$3,170
Omeprazole164$2,764
Balsalazide Disodium14$2,152
SutabSod Sulf/Pot Chloride/Mag Sulf13$2,075
Pantoprazole Sodium174$2,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$794$159,525156 claims
Aimmune Therapeutics, Inc.Zenpep$184$18,30715 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$258$9,10214 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$65$7,06913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →